NCT05407662View on ClinicalTrials.gov

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

June 13, 2023

Study Completion Date

June 13, 2023

Conditions
Chronic Kidney DiseaseType 2 Diabetes MellitusHeart Failure
Interventions
OTHER

sMRA therapies

No drug will be provided to participants. Patients follow routine clinical practice/administration.

Trial Locations (1)

07981

Many Locations, Whippany

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05407662 - A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US | Biotech Hunter | Biotech Hunter